• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年 4 月至 5 月,斯里兰卡科伦坡人口密集地区的 COVID-19 疫情的传播动态、临床特征和血清监测。

Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.

机构信息

Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.

Colombo Municipal Council, Colombo, Sri Lanka.

出版信息

PLoS One. 2021 Nov 8;16(11):e0257548. doi: 10.1371/journal.pone.0257548. eCollection 2021.

DOI:10.1371/journal.pone.0257548
PMID:34748557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8575179/
Abstract

BACKGROUND

The transmission dynamics of SARS-CoV-2 varies depending on social distancing measures, circulating SARS-CoV-2 variants, host factors and other environmental factors. We sought to investigate the clinical and epidemiological characteristics of a SARS-CoV-2 outbreak that occurred in a highly dense population area in Colombo, Sri Lanka from April to May 2020.

METHODOLOGY/PRINCIPAL FINDINGS: We carried out RT-qPCR for SARS-CoV2, assessed the SARS-CoV-2 specific total and neutralizing antibodies (Nabs) in a densely packed, underserved settlement (n = 2722) after identification of the index case on 15th April 2020. 89/2722 individuals were detected as infected by RT-qPCR with a secondary attack rate among close contacts being 0.077 (95% CI 0.063-0.095). Another 30 asymptomatic individuals were found to have had COVID-19 based on the presence of SARS-CoV-2 specific antibodies. However, only 61.5% of those who were initially seropositive for SARS-CoV-2 had detectable total antibodies at 120 to 160 days, while only 40.6% had detectable Nabs. 74/89 (83.1%) of RT-qPCR positive individuals were completely asymptomatic and all 15 (16.9%) who experienced symptoms were classified as having a mild illness. 18 (20.2%) were between the ages of 61 to 80. 11/89 (12.4%) had diabetes, 8/89 (9%) had cardiovascular disease and 4 (4.5%) had asthma. Of the two viruses that were sequenced and were of the B.1 and B.4 lineages with one carrying the D614G mutation.

DISCUSSION/CONCLUSION: Almost all infected individuals developed mild or asymptomatic illness despite the presence of comorbid illnesses. Since the majority of those who were in this underserved settlement were not infected despite circulation of the D614G variant, it would be important to further study environmental and host factors that lead to disease severity and transmission.

摘要

背景

SARS-CoV-2 的传播动力学因社交距离措施、循环中的 SARS-CoV-2 变体、宿主因素和其他环境因素而有所不同。我们试图调查 2020 年 4 月至 5 月在斯里兰卡科伦坡人口稠密地区发生的 SARS-CoV-2 暴发的临床和流行病学特征。

方法/主要发现:我们对 SARS-CoV2 进行了 RT-qPCR 检测,并在 2020 年 4 月 15 日发现首例病例后,对一个人口稠密、服务不足的定居点(n = 2722)中的 SARS-CoV-2 特异性总抗体和中和抗体(Nabs)进行了评估。有 89/2722 人通过 RT-qPCR 检测出感染,密切接触者的二次攻击率为 0.077(95%CI 0.063-0.095)。另有 30 名无症状个体根据存在 SARS-CoV-2 特异性抗体被诊断为 COVID-19。然而,在 120 至 160 天内,只有 61.5%最初 SARS-CoV-2 血清阳性者的总抗体可检测到,而只有 40.6%的人可检测到 Nabs。89 名 RT-qPCR 阳性者中有 74 名(83.1%)完全无症状,所有 15 名(16.9%)出现症状者均被归类为轻症。18 名(20.2%)年龄在 61 至 80 岁之间。11/89(12.4%)患有糖尿病,8/89(9%)患有心血管疾病,4 名(4.5%)患有哮喘。测序的两种病毒属于 B.1 和 B.4 谱系,其中一种携带 D614G 突变。

讨论/结论:尽管存在合并症,但几乎所有感染个体均出现轻度或无症状疾病。由于该服务不足的定居点中的大多数人尽管存在 D614G 变体的传播,但并未感染,因此进一步研究导致疾病严重程度和传播的环境和宿主因素非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2952/8575179/dbae004770c7/pone.0257548.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2952/8575179/dbae004770c7/pone.0257548.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2952/8575179/dbae004770c7/pone.0257548.g001.jpg

相似文献

1
Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.2020 年 4 月至 5 月,斯里兰卡科伦坡人口密集地区的 COVID-19 疫情的传播动态、临床特征和血清监测。
PLoS One. 2021 Nov 8;16(11):e0257548. doi: 10.1371/journal.pone.0257548. eCollection 2021.
2
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.斯里兰卡科伦坡市地区 SARS-CoV-2 感染的血清阳性率。
Front Public Health. 2021 Nov 12;9:724398. doi: 10.3389/fpubh.2021.724398. eCollection 2021.
3
Outbreak investigation of SARS-CoV-2 transmission in an emergency childcare centre.突发公共卫生事件应急托儿所新型冠状病毒传播暴发调查。
Can J Public Health. 2021 Aug;112(4):566-575. doi: 10.17269/s41997-021-00544-1. Epub 2021 May 28.
4
Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.哥伦比亚加勒比地区一组有症状和无症状 SARS-CoV-2 个体的流行病学和病毒特征。
Ann Clin Microbiol Antimicrob. 2020 Dec 7;19(1):58. doi: 10.1186/s12941-020-00397-5.
5
Pre-vaccination RT-PCR negative contacts in workplace settings show high, SARS COV-2 neutralizing antibody levels.工作场所环境中接种疫苗前 RT-PCR 阴性接触者具有较高的 SARS-CoV-2 中和抗体水平。
BMC Public Health. 2022 Oct 25;22(1):1961. doi: 10.1186/s12889-022-14381-5.
6
Dynamic and features of SARS-CoV-2 infection in Gabon.加蓬的 SARS-CoV-2 感染的动态和特征。
Sci Rep. 2021 May 6;11(1):9672. doi: 10.1038/s41598-021-87043-y.
7
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
8
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.在犹太教堂社区爆发的 SARS-CoV-2:抗 SARS-CoV-2 IgG 反应的持久性和强度。
Epidemiol Infect. 2021 Jun 24;149:e153. doi: 10.1017/S0950268821001369.
9
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.苏格兰对 COVID-19 的强化监测:在疫情第一波期间对 SARS-CoV-2 进行基于人群的血清流行率监测。
Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24.
10
Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.韩国两波 SARS-CoV-2 疫情的传播动态和控制。
BMC Infect Dis. 2021 May 26;21(1):485. doi: 10.1186/s12879-021-06204-6.

引用本文的文献

1
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals.鉴定自然感染和接种疫苗个体中 SARS-CoV-2 核衣壳抗体反应的幅度和特异性差异。
Clin Exp Immunol. 2024 Feb 19;215(3):268-278. doi: 10.1093/cei/uxad066.
2
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.斯里兰卡孕妇对国药集团中国生物北京生物制品研究所新冠病毒灭活疫苗(Vero细胞)的抗体反应。
PLOS Glob Public Health. 2022 Jul 18;2(7):e0000607. doi: 10.1371/journal.pgph.0000607. eCollection 2022.
3
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals.

本文引用的文献

1
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.急性 COVID-19 疾病不同严重程度患者中的 SARS-CoV-2 中和抗体。
Sci Rep. 2021 Jan 21;11(1):2062. doi: 10.1038/s41598-021-81629-2.
2
Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.2019年冠状病毒病老年患者的临床特征及严重事件的危险因素
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):542-548. doi: 10.11817/j.issn.1672-7347.2020.200292.
3
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
鉴定自然感染和接种疫苗个体中SARS-CoV-2核衣壳抗体反应在强度和特异性上的差异。
medRxiv. 2023 Jan 7:2023.01.05.23284247. doi: 10.1101/2023.01.05.23284247.
4
Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.接种 BNT162b2 加强针或自然感染后,国药/BBIBP-CorV 疫苗接种者对不同 SARS-CoV-2 蛋白的抗体反应动力学和幅度的比较。
PLoS One. 2022 Oct 13;17(10):e0274845. doi: 10.1371/journal.pone.0274845. eCollection 2022.
5
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.斯里兰卡五种 COVID-19 疫苗的免疫原性比较。
Immunology. 2022 Oct;167(2):263-274. doi: 10.1111/imm.13535. Epub 2022 Jul 9.
6
Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection.两种世界卫生组织批准的 SARS-CoV-2 抗原检测试剂盒在检测 SARS-CoV-2 感染患者中的敏感性和特异性。
BMC Infect Dis. 2022 Mar 22;22(1):276. doi: 10.1186/s12879-022-07240-6.
SARS-CoV-2 基因组中主要缺失对感染严重程度和炎症反应的影响:一项观察性队列研究。
Lancet. 2020 Aug 29;396(10251):603-611. doi: 10.1016/S0140-6736(20)31757-8. Epub 2020 Aug 18.
4
COVID-19 Containment in Asia's Largest Urban Slum Dharavi-Mumbai, India: Lessons for Policymakers Globally.印度孟买最大城市贫民窟达拉维的新冠疫情防控:给全球政策制定者的经验教训
J Urban Health. 2020 Dec;97(6):796-801. doi: 10.1007/s11524-020-00474-2.
5
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.一种基于抗体介导的 ACE2-刺突蛋白-蛋白相互作用阻断的 SARS-CoV-2 假病毒中和试验。
Nat Biotechnol. 2020 Sep;38(9):1073-1078. doi: 10.1038/s41587-020-0631-z. Epub 2020 Jul 23.
6
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
7
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.一种用于 SARS-CoV-2 谱系的动态命名建议,以辅助基因组流行病学研究。
Nat Microbiol. 2020 Nov;5(11):1403-1407. doi: 10.1038/s41564-020-0770-5. Epub 2020 Jul 15.
8
Risk factors for mortality among COVID-19 patients.COVID-19 患者死亡的风险因素。
Diabetes Res Clin Pract. 2020 Aug;166:108293. doi: 10.1016/j.diabres.2020.108293. Epub 2020 Jul 3.
9
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.COVID-19 住院患者死亡的预测因素:系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1875-1883. doi: 10.1002/jmv.26050. Epub 2020 Jul 11.
10
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.SARS-CoV-2 刺突蛋白中与 ACE2 和中和抗体相互作用的受体结合基序的关键残基。
Cell Mol Immunol. 2020 Jun;17(6):621-630. doi: 10.1038/s41423-020-0458-z. Epub 2020 May 15.